Pulling SEC filings + quote and writing the call…

Sight Sciences, Inc.
Next earnings Aug 5, 2026 · consensus $-0.16 EPS, $22.1M rev
Last earnings -0.7% on 2026-05-06
Conservative balance sheet (liabilities/equity 0.80x); but revenue declined -3.1% YoY.
Sight Sciences, Inc. shows $77.4M in FY2025 revenue (-3.1% YoY), a -49.7% net margin, and -60.1% ROE.
Sources: SEC EDGAR (CIK 0001531177, latest 10-Q filed 2026-05-06) · EODHD · as of 6/26/2026, 7:11:17 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $49.0M | $71.3M | $81.1M | $79.9M | $77.4M |
| Gross profit | $40.3M | $59.0M | $69.2M | $68.3M | $66.7M |
| Operating income | -$51.5M | -$84.0M | -$57.3M | -$50.5M | -$37.1M |
| Net income | -$63.0M | -$86.2M | -$55.5M | -$51.5M | -$38.4M |
| Diluted EPS | -$2.36 | -$1.80 | -$1.14 | -$1.03 | -$0.74 |
| Net margin | -128.6% | -120.9% | -68.5% | -64.5% | -49.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1049 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 1 open-market buy · 2 sales
| 2026-06-10 | Encrantz Staffan Director | Buy | 14.1K @ $4.88 | $68.8K |
| 2026-06-04 | Fountain Tamara Director | Award | 28.3K | |
| 2026-06-04 | Encrantz Staffan Director | Award | 28.3K | |
| 2026-06-04 | Burbach Gerhard F Director | Award | 28.3K | |
| 2026-06-04 | Zurbay Donald Director | Award | 28.3K | |
| 2026-06-04 | Mazzacco Catherine Director | Award | 28.3K | |
| 2026-05-18 | Bauerlein Alison Chief Operating Officer | Sell | 12.7K @ $5.12 | $65.2K |
| 2026-04-06 | Rodberg James Chief Financial Officer | Sell | 7.23K @ $3.55 | $25.7K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.